SCHEMBL19797356

SCHEMBL19797356

CC1(C)c2ccccc2N(c2ccc(P(=O)(c3ccncc3)c3ccc(N4c5ccccc5C(C)(C)c5ccccc54)cc3)cc2)c2ccccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.42
▸ CYP1A2 P05177 2/20 0.42
▸ CYP2D6 P10635 2/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ THPO P40225 1/20 0.42
▸ MAPK1 P28482 1/20 0.40
▸ KMT2A Q03164 4/20 0.37
▸ HTT P42858 3/20 0.37
▸ MAPT P10636 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ LMNA P02545 3/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ THRB P10828 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ RECQL P46063 1/20 0.35
▸ AR P10275 1/20 0.34
▸ PGR P06401 5/20 0.33
▸ HDAC1 Q13547 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13231589 0.88 LMNA (0.39) ALDH1A1CYP1A2CYP2D6CYP3A4CYP2C9
SCHEMBL19797359 0.88 LMNA (0.40) ALDH1A1CYP1A2CYP2D6CYP3A4CYP2C9
SCHEMBL19797354 0.87 LMNA (0.40) ALDH1A1CYP1A2CYP2D6CYP3A4CYP2C9
SCHEMBL19269442 0.84 CYP1A2 (0.43) ALDH1A1CYP1A2CYP2D6CYP3A4CYP2C9
SCHEMBL17123064 0.83 ALDH1A1 (0.48) ALDH1A1CYP1A2CYP2D6CYP3A4CYP2C9
SCHEMBL19797355 0.83 EGLN1 (0.34) ALDH1A1CYP1A2CYP2D6CYP3A4CYP2C9
SCHEMBL19797383 0.81 ALDH1A1 (0.38) ALDH1A1CYP1A2CYP2D6CYP3A4CYP2C9
SCHEMBL19268894 0.80 CYP1A2 (0.41) ALDH1A1CYP1A2CYP2D6CYP3A4CYP2C9
SCHEMBL19797366 0.80 PGR (0.32) ALDH1A1CYP1A2CYP2D6CYP3A4CYP2C9
SCHEMBL13231623 0.80 PGR (0.38) ALDH1A1CYP1A2CYP2D6CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10388889-B2 Substituted phosphines as components of organic light-emitting devices SAMSUNG DISPLAY CO., LTD. (KR) 2019-08-20 — — US disclosed
US-20180026206-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-25 — — US disclosed
US-20180026206-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180026206-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CYP1A1, CYP1B1 ALDH1A1 24/4885CYP1A2 7/4885CYP2D6 35/4885
US-10388889-B2 Substituted phosphines as components of organic light-emitting devices CRY1, CRY2, PER2 ALDH1A1 364/4885CYP1A2 571/4885CYP2D6 1356/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback